ONLY A MONTH away from REVENUE from liver assays used for tox screening testing of new drugs...
THEN INCREASING REVENUES as MORE USERS purchase testing assays...
and ONVO branches out into MORE TYPES of tissues available for tox screening testing!
GOOD company/investment soon to be BETTER company/investment evolving into EXCELLENT company/investment as the next 4-6 years pass... who knows what 10 years will bring!
BUT... just ponder what 29,500 becomes at 100! lol